Elevation Oncology, Inc.
NASDAQ:ELEV
0.5108 (USD) • At close March 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.039 | 0.027 | 0.018 | 0.015 | 0 |
| Gross Profit
| 0 | -0.039 | -0.027 | -0.018 | -0.015 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 28.597 | 25.434 | 78.717 | 23.595 | 15.476 | 5.338 |
| General & Administrative Expenses
| 16.106 | 14.904 | 15.832 | 8.451 | 1.8 | 0.816 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0.543 |
| SG&A
| 16.106 | 14.904 | 15.832 | 8.451 | 1.8 | 0.544 |
| Other Expenses
| 0 | 5.107 | -0.506 | 0.007 | 0.011 | 0 |
| Operating Expenses
| 44.703 | 45.445 | 94.549 | 32.046 | 17.276 | 5.882 |
| Operating Income
| -44.703 | -45.445 | -94.549 | -32.046 | -17.276 | -5.882 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.261 | -0.229 | -0.506 | 0.007 | 0.011 | 0 |
| Income Before Tax
| -44.442 | -45.674 | -95.055 | -32.039 | -17.265 | -5.882 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.043 | 0.03 | 0.025 | -0.219 | -0.191 | -0.009 |
| Net Income
| -44.485 | -45.704 | -95.08 | -32.039 | -17.265 | -5.882 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.78 | -1.34 | -4.09 | -1.38 | -0.73 | -0.25 |
| EPS Diluted
| -0.78 | -1.34 | -4.09 | -1.38 | -0.73 | -0.25 |
| EBITDA
| -44.703 | -41.467 | -94.522 | -32.028 | -17.25 | -5.882 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |